THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 156 filers reported holding THERAPEUTICSMD INC in Q3 2019. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,000 | -20.0% | 11,508 | -12.8% | 0.00% | – |
| Q4 2021 | $5,000 | -81.5% | 13,191 | -64.0% | 0.00% | -100.0% |
| Q3 2021 | $27,000 | -38.6% | 36,642 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $44,000 | 0.0% | 36,596 | +10.5% | 0.00% | -50.0% |
| Q1 2021 | $44,000 | +51.7% | 33,108 | +37.2% | 0.00% | +100.0% |
| Q4 2020 | $29,000 | -12.1% | 24,130 | +15.5% | 0.00% | -50.0% |
| Q3 2020 | $33,000 | +26.9% | 20,883 | +2.3% | 0.00% | +100.0% |
| Q2 2020 | $26,000 | +30.0% | 20,421 | +8.3% | 0.00% | -50.0% |
| Q1 2020 | $20,000 | -61.5% | 18,859 | -12.1% | 0.00% | 0.0% |
| Q4 2019 | $52,000 | -11.9% | 21,448 | +31.9% | 0.00% | -33.3% |
| Q3 2019 | $59,000 | +20.4% | 16,260 | -14.0% | 0.00% | +50.0% |
| Q2 2019 | $49,000 | -56.6% | 18,904 | -18.6% | 0.00% | -60.0% |
| Q1 2019 | $113,000 | -35.4% | 23,237 | -49.5% | 0.01% | -54.5% |
| Q4 2018 | $175,000 | -50.3% | 46,050 | -14.2% | 0.01% | -15.4% |
| Q3 2018 | $352,000 | – | 53,679 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 1,575,000 | $10,080,000 | 0.84% |
| MORGENS WATERFALL VINTIADIS & CO INC | 180,000 | $1,152,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 5,045,685 | $32,292,000 | 0.63% |
| EAM Investors, LLC | 508,483 | $3,254,000 | 0.51% |
| STONERIDGE INVESTMENT PARTNERS LLC | 468,986 | $3,002,000 | 0.44% |
| 1492 Capital Management LLC | 41,132 | $263,000 | 0.22% |
| HEARTLAND ADVISORS INC | 600,000 | $3,840,000 | 0.20% |
| OUTFITTER ADVISORS, LTD. | 63,532 | $407,000 | 0.16% |
| Piermont Capital Management Inc. | 66,240 | $424,000 | 0.14% |
| GAM Holding AG | 1,202,729 | $7,697,000 | 0.13% |